Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
93.17 CHF | +2.13% | +1.56% | +9.78% |
Jun. 02 | Pre-surgery treatment with Bristol Myers combination therapy leads to better skin cancer outcomes | RE |
May. 31 | NOVARTIS AG : UBS reiterates its Buy rating | ZD |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Other languages